| Primary |
| Drug Use For Unknown Indication |
26.6% |
| Product Used For Unknown Indication |
23.4% |
| Diagnostic Procedure |
9.8% |
| Back Pain |
6.6% |
| Abdominal Pain |
5.4% |
| Pulmonary Embolism |
3.5% |
| Computerised Tomogram |
2.8% |
| Aortic Aneurysm |
2.5% |
| Angina Pectoris |
2.2% |
| Colon Cancer |
2.2% |
| Myocardial Infarction |
2.2% |
| Rectal Cancer |
1.9% |
| Chest Pain |
1.6% |
| Coronary Artery Disease |
1.6% |
| Abdominal Pain Lower |
1.3% |
| Appendicitis |
1.3% |
| Central Venous Catheterisation |
1.3% |
| Intracranial Aneurysm |
1.3% |
| Metastases To Liver |
1.3% |
| Pancreatic Pseudocyst |
1.3% |
|
| Anaphylactoid Reaction |
17.4% |
| Vomiting |
11.6% |
| Urticaria |
7.6% |
| Loss Of Consciousness |
5.2% |
| Renal Failure Acute |
4.7% |
| Respiratory Arrest |
4.7% |
| Anaphylactoid Shock |
4.1% |
| Blood Urea Increased |
4.1% |
| Chills |
4.1% |
| Dyspnoea |
4.1% |
| Bacteraemia |
3.5% |
| Death |
3.5% |
| Extravasation |
3.5% |
| Meningitis Bacterial |
3.5% |
| Post Procedural Complication |
3.5% |
| Shock |
3.5% |
| Hypersensitivity |
2.9% |
| Injection Site Extravasation |
2.9% |
| Myocardial Infarction |
2.9% |
| Nausea |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
18.7% |
| Nuclear Magnetic Resonance Imaging |
10.0% |
| Drug Use For Unknown Indication |
7.1% |
| Diagnostic Procedure |
6.7% |
| Angiogram |
5.8% |
| Computerised Tomogram |
5.6% |
| Hypertension |
4.7% |
| Pain |
4.7% |
| Venogram |
4.2% |
| Fistulogram |
4.0% |
| Nuclear Magnetic Resonance Imaging Brain |
3.8% |
| Computerised Tomogram Abdomen |
3.3% |
| Diabetes Mellitus |
3.1% |
| Angina Pectoris |
2.9% |
| Constipation |
2.7% |
| Prophylaxis |
2.7% |
| Skin Test |
2.7% |
| Skin Test Positive |
2.7% |
| Thrombosis Prophylaxis |
2.4% |
| Prophylaxis Against Transplant Rejection |
2.2% |
|
| Renal Failure Acute |
10.4% |
| Vomiting |
10.4% |
| Bacteraemia |
7.8% |
| Drug Hypersensitivity |
7.8% |
| Nausea |
6.5% |
| Rash |
6.5% |
| Skin Ulcer |
6.5% |
| Weight Decreased |
5.2% |
| Blood Creatinine Increased |
3.9% |
| Drug Interaction |
3.9% |
| Renal Failure |
3.9% |
| Shock |
3.9% |
| Thrombocytopenia |
3.9% |
| Tremor |
3.9% |
| Amnesia |
2.6% |
| Anaphylactoid Reaction |
2.6% |
| Chills |
2.6% |
| Death |
2.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.6% |
| Hypertension |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.1% |
| Nuclear Magnetic Resonance Imaging |
10.7% |
| Coronary Artery Bypass |
8.3% |
| Catheterisation Cardiac |
5.8% |
| Angiogram |
5.4% |
| Drug Use For Unknown Indication |
4.0% |
| Computerised Tomogram |
3.7% |
| Prophylaxis |
3.6% |
| Pain |
3.5% |
| Hypertension |
3.1% |
| Hepatic Neoplasm Malignant |
2.7% |
| Muscle Spasms |
2.1% |
| Aortic Valve Replacement |
2.0% |
| Venogram |
1.8% |
| Infection |
1.7% |
| Colonoscopy |
1.6% |
| Facet Joint Block |
1.6% |
| Musculoskeletal Pain |
1.4% |
| Nuclear Magnetic Resonance Imaging Brain |
1.4% |
| Fistulogram |
1.4% |
|
| Injury |
10.3% |
| Pain |
9.5% |
| Anxiety |
8.7% |
| Renal Failure |
8.3% |
| Unevaluable Event |
7.9% |
| Emotional Distress |
6.6% |
| Anhedonia |
5.4% |
| Fear |
5.4% |
| Weight Decreased |
5.4% |
| Stress |
4.1% |
| Dry Skin |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Oedema Peripheral |
3.3% |
| Urticaria |
3.3% |
| Depression |
2.9% |
| Discomfort |
2.9% |
| Diarrhoea |
2.5% |
| Rhabdomyolysis |
2.5% |
| Skin Ulcer |
2.5% |
| Renal Impairment |
2.1% |
|
| Interacting |
| Atrial Fibrillation |
50.0% |
| Type 2 Diabetes Mellitus |
50.0% |
|
| Vomiting |
75.0% |
| Renal Failure |
25.0% |
|
